Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/27670
GALECTIN-3 IMPACTS CRYPTOCOCCUS NEOFORMANS INFECTION THROUGH DIRECT ANTIFUNGAL EFFECTS
Author
Affilliation
University of Sao Paulo. Ribeirao Preto Medical School. Department of Biochemistry and Immunology. Ribeirao Preto, SP, Brasil.
Yeshiva University. Albert Einstein College of Medicine. Department of Microbiology and Immunology. New York, NY, EUA.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
Yeshiva University. Albert Einstein College of Medicine. Department of Microbiology and Immunology. New York, NY, EUA.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Biochemistry and Immunology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Biochemistry and Immunology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School . Department of Internal Medicine. Ribeirao Preto, SP, Brasil.
Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Paulo de Goes. Rio de Janeiro, RJ, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
Johns Hopkins Bloomberg School of Public Health. Department of Molecular Microbiology and Immunology. Baltimore, MD, EUA.
Yeshiva University. Albert Einstein College of Medicine. Department of Microbiology and Immunology. New York, NY, EUA.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
Yeshiva University. Albert Einstein College of Medicine. Department of Microbiology and Immunology. New York, NY, EUA.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Biochemistry and Immunology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Biochemistry and Immunology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School . Department of Internal Medicine. Ribeirao Preto, SP, Brasil.
Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Paulo de Goes. Rio de Janeiro, RJ, Brasil.
University of Sao Paulo. Ribeirao Preto Medical School. Department of Cellular and Molecular Biology. Ribeirao Preto, SP, Brasil.
Johns Hopkins Bloomberg School of Public Health. Department of Molecular Microbiology and Immunology. Baltimore, MD, EUA.
Abstract
Cryptococcus neoformans is an encapsulated fungal pathogen that causes cryptococcosis, which is a major opportunistic infection in immunosuppressed individuals. Mammalian β-galactoside-binding protein Galectin-3 (Gal-3) modulates the host innate and adaptive immunity, and plays significant roles during microbial infections including some fungal diseases. Here we show that this protein plays a role also in C. neoformans infection. We find augmented Gal-3 serum levels in human and experimental infections, as well as in spleen, lung, and brain tissues of infected mice. Gal-3-deficient mice are more susceptible to cryptococcosis than WT animals, as demonstrated by the higher fungal burden and lower animal survival. In vitro experiments show that Gal-3 inhibits fungal growth and exerts a direct lytic effect on C. neoformans extracellular vesicles (EVs). Our results indicate a direct role for Gal-3 in antifungal immunity whereby this molecule affects the outcome of C. neoformans infection by inhibiting fungal growth and reducing EV stability, which in turn could benefit the host.
Share